These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 28151504)
1. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies]. Monti M; Borgognoni F; Pastacci L; Vincentelli GM G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504 [TBL] [Abstract][Full Text] [Related]
2. The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement. Amoroso A; Cacciapaglia F; De Castro S; Battagliese A; Coppolino G; Galluzzo S; Vadacca M; Afeltra A Clin Exp Rheumatol; 2006; 24(3):287-94. PubMed ID: 16870096 [TBL] [Abstract][Full Text] [Related]
3. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Farzaneh-Far A; Roman MJ; Lockshin MD; Devereux RB; Paget SA; Crow MK; Davis A; Sammaritano L; Levine DM; Salmon JE Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599 [TBL] [Abstract][Full Text] [Related]
4. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539 [TBL] [Abstract][Full Text] [Related]
5. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865 [TBL] [Abstract][Full Text] [Related]
6. HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus. Lundström E; Gustafsson JT; Jönsen A; Leonard D; Zickert A; Elvin K; Sturfelt G; Nordmark G; Bengtsson AA; Sundin U; Källberg H; Sandling JK; Syvänen AC; Klareskog L; Gunnarsson I; Rönnblom L; Padyukov L; Svenungsson E Ann Rheum Dis; 2013 Jun; 72(6):1018-25. PubMed ID: 22893315 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus. Amoroso A; Mitterhofer AP; Del Porto F; Garzia P; Ferri GM; Galluzzo S; Vadacca M; Caccavo D; Afeltra A Hum Immunol; 2003 Feb; 64(2):265-73. PubMed ID: 12559629 [TBL] [Abstract][Full Text] [Related]
8. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
9. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus. Taraborelli M; Lazzaroni MG; Martinazzi N; Fredi M; Cavazzana I; Franceschini F; Tincani A Reumatismo; 2016 Dec; 68(3):137-143. PubMed ID: 27981815 [TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus. Cabral AR; Cabiedes J; Alarcón-Segovia D Lupus; 2004; 13(3):182-7. PubMed ID: 15119547 [TBL] [Abstract][Full Text] [Related]
11. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome]. Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
13. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies. Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581 [TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. Cabiedes J; Cabral AR; Alarcón-Segovia D J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989 [TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800 [TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular abnormalities in systemic lupus erythematosus patients in echocardiographic assessment]. Ostanek L; Płońska E; Peregud-Pogorzelska M; Mokrzycki K; Brzosko M; Fischer K; Fliciński J Pol Merkur Lekarski; 2006 Mar; 20(117):305-8. PubMed ID: 16780262 [TBL] [Abstract][Full Text] [Related]
19. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Leung WH; Wong KL; Lau CP; Wong CK; Liu HW Am J Med; 1990 Oct; 89(4):411-9. PubMed ID: 2121029 [TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus. Ruiz D; Oates JC; Kamen DL Am J Med Sci; 2018 Mar; 355(3):293-298. PubMed ID: 29549933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]